Stimuli-responsive Liposomes for Drug Delivery

Overview

Journal Wiley Interdiscip Rev Nanomed Nanobiotechnol

Specialty Biotechnology

Date 2017 Feb 16

PMID 28198148

Citations 129

Authors

Y Lee

D H Thompson

Affiliations

Soon will be listed here.

Abstract

The ultimate goal of drug delivery is to increase the bioavailability and reduce the toxic side effects of the active pharmaceutical ingredient (API) by releasing them at a specific site of action. In the case of antitumor therapy, association of the therapeutic agent with a carrier system can minimize damage to healthy, nontarget tissues, while limit systemic release and promoting long circulation to enhance uptake at the cancerous site due to the enhanced permeation and retention effect (EPR). Stimuli-responsive systems have become a promising way to deliver and release payloads in a site-selective manner. Potential carrier systems have been derived from a wide variety of materials, including inorganic nanoparticles, lipids, and polymers that have been imbued with stimuli-sensitive properties to accomplish triggered release based on an environmental cue. The unique features in the tumor microenvironment can serve as an endogenous stimulus (pH, redox potential, or unique enzymatic activity) or the locus of an applied external stimulus (heat or light) to trigger the controlled release of API. In liposomal carrier systems triggered release is generally based on the principle of membrane destabilization from local defects within bilayer membranes to effect release of liposome-entrapped drugs. This review focuses on the literature appearing between November 2008-February 2016 that reports new developments in stimuli-sensitive liposomal drug delivery strategies using pH change, enzyme transformation, redox reactions, and photochemical mechanisms of activation. WIREs Nanomed Nanobiotechnol 2017, 9:e1450. doi: 10.1002/wnan.1450 For further resources related to this article, please visit the WIREs website.

Citing Articles

Lipid Nanovesicles in Cancer Treatment: Improving Targeting and Stability of Antisense Oligonucleotides.

Ding H, Zhou H, Jiang Y, Chen S, Wu X, Li Y Drug Des Devel Ther. 2025; 19:1001-1023.

PMID: 39967902 PMC: 11834698. DOI: 10.2147/DDDT.S507402.

Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects.

Cheng Z, Huang H, Yin M, Liu H Exp Hematol Oncol. 2025; 14(1):11.

PMID: 39891180 PMC: 11786384. DOI: 10.1186/s40164-025-00602-1.

The modification of conventional liposomes for targeted antimicrobial delivery to treat infectious diseases.

Okafor N, Omoteso O, Choonara Y Discov Nano. 2025; 20(1):19.

PMID: 39883380 PMC: 11782757. DOI: 10.1186/s11671-024-04170-x.

Liposomal Formulations: A Recent Update.

Agrawal S, Baliga V, Londhe V Pharmaceutics. 2025; 17(1).

PMID: 39861685 PMC: 11769406. DOI: 10.3390/pharmaceutics17010036.

Utilizing nanomaterials for cancer treatment and diagnosis: an overview.

Mukhopadhyay B, Singh S, Singh A Discov Nano. 2024; 19(1):215.

PMID: 39718700 PMC: 11668726. DOI: 10.1186/s11671-024-04128-z.

References

Torres E, Mainini F, Napolitano R, Fedeli F, Cavalli R, Aime S . Improved paramagnetic liposomes for MRI visualization of pH triggered release. J Control Release. 2011; 154(2):196-202. DOI: 10.1016/j.jconrel.2011.05.017. View

Wang Y, Zhang L, Guo S, Hatefi A, Huang L . Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery. J Control Release. 2013; 172(1):179-189. PMC: 5020560. DOI: 10.1016/j.jconrel.2013.08.015. View

Zheng Y, Liu X, Samoshina N, Samoshin V, Franz A, Guo X . trans-2-Aminocyclohexanol-based amphiphiles as highly efficient helper lipids for gene delivery by lipoplexes. Biochim Biophys Acta. 2015; 1848(12):3113-25. DOI: 10.1016/j.bbamem.2015.08.021. View

Xie X, Yang Y, Yang Y, Mei X . Photolabile-caged peptide-conjugated liposomes for siRNA delivery. J Drug Target. 2015; 23(9):789-99. DOI: 10.3109/1061186X.2015.1009077. View

Reshetov V, Lassalle H, Francois A, Dumas D, Hupont S, Grafe S . Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo. Int J Nanomedicine. 2013; 8:3817-31. PMC: 3797282. DOI: 10.2147/IJN.S51002. View

Zhu G, Alhamhoom Y, Cummings B, Arnold R . Synthesis of lipids for development of multifunctional lipid-based drug-carriers. Bioorg Med Chem Lett. 2011; 21(21):6370-5. PMC: 3195505. DOI: 10.1016/j.bmcl.2011.08.103. View

Guo C, Liu S, Jiang C, Li W, Dai Z, Fritz H . A promising drug controlled-release system based on diacetylene/phospholipid polymerized vesicles. Langmuir. 2009; 25(22):13114-9. DOI: 10.1021/la9034112. View

Kumari A, Yadav S, Yadav S . Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2009; 75(1):1-18. DOI: 10.1016/j.colsurfb.2009.09.001. View

McCarley R, Forsythe J, Loew M, Mendoza M, Hollabaugh N, Winter J . Release rates of liposomal contents are controlled by kosmotropes and chaotropes. Langmuir. 2013; 29(46):13991-5. PMC: 3932753. DOI: 10.1021/la402740k. View

10.

Ding Y, Sun D, Wang G, Yang H, Xu H, Chen J . An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery. Int J Nanomedicine. 2015; 10:6199-214. PMC: 4598226. DOI: 10.2147/IJN.S92519. View

11.

Hu Y, Zhao Z, Ehrich M, Fuhrman K, Zhang C . controlled release of antigen in dendritic cells using pH-sensitive liposome-polymeric hybrid nanoparticles. Polymer (Guildf). 2015; 80:171-179. PMC: 4662652. DOI: 10.1016/j.polymer.2015.10.048. View

12.

Li Q, Tang Q, Zhang P, Wang Z, Zhao T, Zhou J . Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes. Biomaterials. 2015; 57:1-11. DOI: 10.1016/j.biomaterials.2015.04.009. View

13.

Mahmoud G, Jedelska J, Strehlow B, Bakowsky U . Bipolar tetraether lipids derived from thermoacidophilic archaeon Sulfolobus acidocaldarius for membrane stabilization of chlorin e6 based liposomes for photodynamic therapy. Eur J Pharm Biopharm. 2015; 95(Pt A):88-98. DOI: 10.1016/j.ejpb.2015.04.009. View

14.

Linderoth L, Peters G, Madsen R, Andresen T . Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties. Angew Chem Int Ed Engl. 2009; 48(10):1823-6. DOI: 10.1002/anie.200805241. View

15.

Pedersen P, Adolph S, Subramanian A, Arouri A, Andresen T, Mouritsen O . Liposomal formulation of retinoids designed for enzyme triggered release. J Med Chem. 2010; 53(9):3782-92. DOI: 10.1021/jm100190c. View

16.

Tripathy N, Ahmad R, Ko H, Khang G, Hahn Y . Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drug-delivery system. Nanoscale. 2015; 7(9):4088-96. DOI: 10.1039/c4nr06979j. View

17.

Zhang S, Zhao Y . Controlled release from cleavable polymerized liposomes upon redox and pH stimulation. Bioconjug Chem. 2011; 22(4):523-8. DOI: 10.1021/bc1003197. View

18.

Araki T, Ogawara K, Suzuki H, Kawai R, Watanabe T, Ono T . Augmented EPR effect by photo-triggered tumor vascular treatment improved therapeutic efficacy of liposomal paclitaxel in mice bearing tumors with low permeable vasculature. J Control Release. 2015; 200:106-14. DOI: 10.1016/j.jconrel.2014.12.038. View

19.

Randles E, Bergethon P . A photodependent switch of liposome stability and permeability. Langmuir. 2013; 29(5):1490-7. DOI: 10.1021/la303526k. View

20.

Pashkovskaya A, Kotova E, Zorlu Y, Dumoulin F, Ahsen V, Agapov I . Light-triggered liposomal release: membrane permeabilization by photodynamic action. Langmuir. 2009; 26(8):5726-33. DOI: 10.1021/la903867a. View